Use of rituximab in the of immunoinflammatory rheumatic diseases combined with Graves' disease (autoimmune polyglandular syndrome in adults): case report and literature review

Rituximab (RTM) is a chimeric (murine and human) monoclonal antibody against B-lymphocytes (CD20). RTM is widely used in hematology for lymphoproliferative diseases and in rheumatology for rheumatoid arthritis, Sjögren's disease, some types of vasculitis and systemic connective tissue diseases....

Full description

Saved in:
Bibliographic Details
Main Authors: T. S. Panevin, E. G. Zotkin
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2024-10-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1646
Tags: Add Tag
No Tags, Be the first to tag this record!